Literature DB >> 8096817

Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study.

A M Ter Laak1, G M Donné-Op den Kelder, A Bast, H Timmerman.   

Abstract

An extended series of structurally different histamine H1 receptor antagonists was investigated for binding at central and peripheral histamine H1 receptors in vitro. Antagonist affinities were measured by displacements of [3H]mepyramine from both guinea-pig cerebellum and lung membrane suspensions. Single [3H]mepyramine binding sites with identical affinity for [3H]mepyramine were found in both tissues; however, the H1 receptor density was 6-fold lower in lungs than in cerebellum. None of the antagonists tested showed substantial preference for either of the receptors. It is concluded from the displacement data that there is no difference between the antagonist binding sites of cerebellum and lung H1 receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096817     DOI: 10.1016/0014-2999(93)90774-c

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Regulation of the human histamine H1 receptor stably expressed in Chinese hamster ovary cells.

Authors:  M J Smit; H Timmerman; J C Hijzelendoorn; H Fukui; R Leurs
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.

Authors:  M Tagawa; M Kano; N Okamura; M Higuchi; M Matsuda; Y Mizuki; H Arai; R Iwata; T Fujii; S Komemushi; T Ido; M Itoh; H Sasaki; T Watanabe; K Yanai
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

4.  Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein.

Authors:  Tanja Obradovic; Glenn G Dobson; Tomotaka Shingaki; Thomas Kungu; Ismael J Hidalgo
Journal:  Pharm Res       Date:  2006-12-19       Impact factor: 4.200

Review 5.  Terfenadine: a mixture of equipotent antihistamine enantiomers without a clear 'isomeric ballast'.

Authors:  M Q Zhang; H Timmerman
Journal:  Pharm World Sci       Date:  1993-10-15

Review 6.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

7.  Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H(1) receptors.

Authors:  Santosh S Kulkarni; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
Journal:  Bioorg Med Chem       Date:  2006-02-03       Impact factor: 3.641

8.  Pharmacological profile of astemizole-derived compounds at the histamine H1 and H4 receptor--H1/H4 receptor selectivity.

Authors:  Eva Wagner; Hans-Joachim Wittmann; Sigurd Elz; Andrea Strasser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-17       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.